The current kidney care model—focused on late-stage disease and in-center hemodialysis—is unsustainable, because of costs, environmental burden, poor outcomes, and reduced quality of life.

Since the 1990s, the FDA has collected fees from drug companies to help pay for stepped-up staffing enable faster reviews of new prescription drugs and vaccines. In turn, the agency must meet certain ...

The FDA grants Fast Track designation to nipocalimab for systemic lupus erythematosus following positive results from the phase 2b JASMINE trial.

The LITESPARK-022 study tested belzutifan, an oral small-molecule inhibitor of hypoxia-inducible factor-2α (HIF-2α) targeting angiogenesis, in combination with standard of care pembrolizumab as ...

Low-dose zoledronic acid appeared safe among older patients with hip fracture and advanced chronic kidney disease.

Whether BCG strains other than BCG TICE are safe and effective for treating high-grade NMIBC warrants rigorous testing.

(HealthDay News) — A chocolate male enhancement product is being pulled from store shelves after federal health officials found it contains a hidden prescription drug. The company — USALESS.COM, based ...

Investigators evaluated patient-reported outcomes and tolerability of capivasertib plus abiterone in PTEN-deficient metastatic hormone-sensitive prostate cancer.

(HealthDay News) — Adult patients with cancer who experience a new-onset mental health disorder (MHD) have an increased risk for death, according to a study published online Feb. 23 in Cancer.

In the absence of trials, a post hoc analysis compared stereotactic body radiotherapy (SBRT) and high-dose-rate brachytherapy (HDR-BT) in intermediate-risk prostate cancer.

(HealthDay News) — Metabolic dysfunction, rather than steatotic liver disease (SLD), seems to be the main driver of chronic kidney disease (CKD) risk, according to research published online Feb. 23 in ...

MARCAP investigators conducted the first individual patient data meta-analysis of randomized trials (POSEIDON) evaluating the use and duration hormone therapy with postoperative radiation therapy in ...